KUKU

KU ScholarWorks

  • myKU
  • Email
  • Enroll & Pay
  • KU Directory
    • Login
    View Item 
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    •   KU ScholarWorks
    • Dissertations and Theses
    • Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    A Novel Molecular Pathway Involving GPR10, REST, and PRICKLE1 in the Pathogenesis of Uterine Leiomyoma

    Thumbnail
    View/Open
    McWilliams_ku_0099D_15151_DATA_1.pdf (122.0Mb)
    Issue Date
    2017-05-31
    Author
    McWilliams, Michelle Marie
    Publisher
    University of Kansas
    Format
    322 pages
    Type
    Dissertation
    Degree Level
    Ph.D.
    Discipline
    Molecular & Integrative Physiology
    Rights
    Copyright held by the author.
    Metadata
    Show full item record
    Abstract
    Uterine Leiomyoma (UL), also known as Uterine Fibroids, are benign, hormone-sensitive tumors arising in the smooth muscle tissue layer of the uterus, the myometrium. UL are the most common female reproductive tract tumors, with lifetime occurrence in up to 77% of all women. A third of women with UL require treatment for clinically significant symptoms of menorrhagia, severe pain, anemia and fertility complications, resulting in over 200,000 hysterectomies and up to $34.4 billion in medical costs in the United States each year. Despite the prevalence of UL, currently no treatment for UL is long-term, cost effective and leaves fertility intact. There is a pressing need to develop better pharmacotherapies for the treatment of UL. Remarkably, very little is known about the molecular pathogenesis of UL. Environmental estrogen exposure is one of the most recognized risk factors associated with the development of UL tumors. At the cellular level, extensive evidence has linked the cell proliferation, survival and growth of UL tumors to the over-activation of the PI3K/AKT-mTOR pathway. This work establishes, for the first time, a comprehensive molecular pathway starting from known environmental estrogen risk factors leading to activation of the most crucial cell proliferation pathway in UL. We identified the most overexpressed G-protein coupled receptor in UL as the neuronspecific GPR10 (PRLHR), which activates the PI3K/AKT-mTOR pathway in UL cells upon stimulation by its ligand, PrRP (Prolactin-Releasing Peptide). Epigenetic silencing of GPR10 in non-neuronal cells is accomplished by the tumor-suppressor REST (Repressor Element Silencing Transcription factor), which we found to be drastically down-regulated at the protein level in UL tissue. In addition to GPR10, many of the most dysregulated genes in UL tissue are direct targets iv of REST, implicating the central role of the loss of REST in the pathogenesis of UL. In our investigations on the degradation of REST in UL, we found significant under-expression of PRICKLE1, the protein required for REST localization to the nucleus. We have found that PRICKLE1 expression in the uterine myometrium is regulated by estrogen through Estrogen Receptor-α and that the loss of PRICKLE1 leads to the destabilization and degradation of REST protein in UL. We found overexpression of the polycomb repressor complex protein EZH2 (Enhancer of Zeste Homolog 2) participates in repression of PRICKLE1 in UL. Furthermore, we provide two important preclinical mouse models, which are among the first in the UL field that recapitulate genes dysregulated in human UL. We show that mice expressing hGPR10 in the uterus, and a conditional knockout of REST in the reproductive tract, show UL phenotype. This work establishes a novel molecular pathway in UL pathogenesis linking upstream estrogen signaling to downstream PI3K/AKT-mTOR pathway activation and provides potential drug targets and preclinical mouse models for improved treatment of UL.
    URI
    http://hdl.handle.net/1808/26943
    Collections
    • KU Med Center Dissertations and Theses [464]
    • Dissertations [4473]

    Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.


    We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.


    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    Browse

    All of KU ScholarWorksCommunities & CollectionsThis Collection

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Contact KU ScholarWorks
    785-864-8983
    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    785-864-8983

    KU Libraries
    1425 Jayhawk Blvd
    Lawrence, KS 66045
    Image Credits
     

     

    The University of Kansas
      Contact KU ScholarWorks
    Lawrence, KS | Maps
     
    • Academics
    • Admission
    • Alumni
    • Athletics
    • Campuses
    • Giving
    • Jobs

    The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.

     Contact KU
    Lawrence, KS | Maps